Monthly Archives: August 2015

Cancer Research UK Funding Preclinical Study with Biothera’s Imprime PGG in Combination Therapy

EAGAN, MN — August 18, 2015 — Cancer Research UK (CRUK), the world’s largest charitable funder of cancer research, will fund preclinical research evaluating the efficacy of Biothera’s investigational cancer immunotherapy Imprime PGG® in combination with monoclonal antibody (MAb) therapies as a precursor to a phase 1-2 clinical study in rituximab-refractory follicular lymphoma. The research will be conducted at the Manchester Academic Health Sciences Centre under the...

Read More